Global

Sep 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Europe's fiscal crisis is becoming a new rallying cry for patient groups—but regional unity is still elusive.
May 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Will changes to the P&R system in the UK finally put some real metrics behind the elusive concept of value?
Apr 02, 2012
By Pharmaceutical Executive Editors
Pharm Exec talks to Carlos Plata, Chief Scientific Officer of Esteve, the Spanish company that is rising above the economic gloom to become a major player in pain.
Apr 01, 2012
Pharmaceutical Executive
India's most prominent scientist, Dr R.A. Mashelkar, President of the Global Research Alliance, on delivering medicines profitably but cheaply to low income countries.
Feb 01, 2012
From Pharmaceutical Technology
By Pharmaceutical Executive Editors
With Europe's economic troubles causing domestic profitability concerns, established pharmaceutical companies may need look to emerging markets for outsourcing partners.
Jan 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
Dec 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Will big investments in infrastructure carry the day in positioning China as a global drug innovation powerhouse?
Dec 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Y.K. Hamied, PhD, Chairman, Cipla
native1_300x100
lorem ipsum